Skip to main content
    H

    HUTCHMED DRC (HCM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $13.48
    -0.02 (-0.15%)

    Market Cap: $2.35B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(21/28)
    Avg Surprise
    +107.10%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Jul 2
    		$N/AN/AN/ABeat-
    Mar 26
    Reported Jun 18
    		$N/AN/AN/ABeat-
    Dec 25
    Reported Mar 23
    		$N/A$0.25N/ABeat-
    Sep 25
    Reported Nov 28
    		$0.00$0.00N/ABeat-
    Jun 25
    Reported Jul 2
    		$0.52$0.00N/ABeat-
    Mar 25
    Reported May 28
    		$0.00$0.00N/ABeat-
    Dec 24
    Reported Mar 19
    		$0.01N/A-75.00%Miss+101.4%
    Sep 24
    Reported Nov 29
    		$0.00$0.00N/ABeat-
    Jun 24
    Reported Jul 31
    		$0.00$0.00N/ABeat-100.0%
    Mar 24
    Reported Jun 10
    		$0.00$0.00N/ABeat-
    Dec 23
    Reported Feb 28
    		$-0.70$-1.08+35.19%Beat+31.4%
    Sep 23
    Reported Nov 10
    		$0.00N/A-100.00%Miss-
    Jun 23
    Reported Jul 31
    		$0.97$-0.06+1863.64%Beat+201.0%
    Mar 23
    Reported Jun 20
    		$0.00N/A+100.00%Beat+100.0%
    Dec 22
    Reported Feb 28
    		$-1.02$-1.02+0.00%Beat-3300.0%
    Sep 22
    Reported Nov 11
    		$0.00N/A+100.00%Beat-
    Jun 22
    Reported Aug 1
    		$-0.96$-0.72-33.33%Miss-140.0%
    Mar 22
    Reported Jun 1
    		$-0.70$-0.70+0.00%Beat-102.3%
    Dec 21
    Reported Mar 2
    		$-0.03N/A+76.92%Beat+0.0%
    Sep 21
    Reported Nov 12
    		$0.00N/A+100.00%Beat+100.0%
    Jun 21
    Reported Jul 28
    		$-0.40$-0.07-471.43%Miss-1233.3%
    Mar 21
    Reported Jun 2
    		$-0.35$-0.36+3.35%Beat-30.5%
    Dec 20
    Reported Mar 4
    		$-0.03N/A+76.92%Beat+88.0%
    Sep 20
    Reported Nov 13
    		$-0.18$-0.21+10.09%Beat-43.4%
    Jun 20
    Reported Jul 30
    		$-0.03N/A+83.33%Beat+80.6%
    Mar 20
    Reported Jun 3
    		$-0.27$-0.32+17.13%Beat-784.0%
    Dec 19
    Reported Mar 3
    		$-0.25$-0.23-8.70%Miss-2400.0%
    Sep 19
    Reported Nov 15
    		$-0.13$-0.17+24.29%Beat-83.9%
    Jun 19
    Reported Jul 30
    		$-0.15$-0.15-3.13%Miss-10.5%
    Mar 19
    Reported Jun 6
    		$-0.03N/A+76.92%Beat+78.6%
    Dec 18
    Reported Mar 31
    		$-0.01N/A+83.33%Beat-200.0%
    Sep 18
    Reported Nov 16
    		$-0.07$-0.07+0.00%Beat-800.0%
    Jun 18
    Reported Jul 26
    		$-0.14$-0.16+12.50%Beat-1500.0%
    Mar 18
    Reported May 30
    		$-0.14$-0.16+12.50%Beat-240.0%
    Dec 17
    Reported Mar 12
    		$0.01$0.01+0.00%Beat-
    Jun 17
    Reported Jul 31
    		$0.01N/A-85.71%Miss-
    Mar 17
    Reported May 31
    		$0.01$0.00N/ABeat-
    Dec 16
    Reported Mar 13
    		$0.10$-0.01+1100.00%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF236.53xFCF Yield0.42%
    Profitability
    Profit Margin3.26%Operating Margin0.31%
    ROE1.46%ROIC-2.35%
    Financial Health
    Debt/Equity0.07xInterest Coverage24.21x
    Current Ratio5.64xQuick Ratio5.50x
    Trading Statistics
    Beta0.36Avg Volume57.07K
    52-Week High$16.3352-Week Low$9.77

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.04
    SMA 20$14.08
    SMA 50$13.24
    SMA 200$13.23
    EMA 10$13.88
    EMA 20$13.86
    EMA 50$13.32
    EMA 200$13.23

    MACD

    Line: 0.14Signal: 0.30Hist: -0.16

    ADX

    ADX: 18.1+DI: 33.2-DI: 31.9

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down8.0
    PSAR$14.78

    Bollinger Bands

    Upper Band$14.80
    Lower Band$13.35
    %B Position1027%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    46.6

    Momentum Oscillators

    Stoch %K12.5
    Stoch %D18.8
    Williams %R-87.9
    ROC (10d)-7.9%
    Momentum-1.15
    CCI (20d)-102.5
    MFI (14d)53.9

    Volatility Measures

    ATR (14d)$0.46(3.4%)
    StdDev (20d)0.36
    Hist Vol42.3%(High)

    Volume Flow

    VWAP$13.65
    OBV1.8M
    AD Line-96.8K
    CMF (20d)0.014

    Volume Metrics

    Avg Vol (20d)57.8K
    Vol Ratio1.4x
    VWMA (20d)$14.16

    Pivot Points

    R3$13.93
    R2$13.75
    R1$13.63
    Pivot Point$13.45
    S1$13.33
    S2$13.15
    S3$13.03

    Advanced Oscillators

    TSI6.65
    Ultimate Osc41.9
    KST74.30

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$139.14M$139.14M$135.42M$135.42M$138.84M$138.84M$162.26M$162.26M$152.84M$152.84M$152.56M$80.25M
    Cost of Revenue$115.47M$115.47M$158.53M$158.53M$83.79M$83.79M$190.43M$190.43M$90.07M$90.07M$239.06M$166.75M
    Gross Profit$23.67M$23.67M$-23,116,000$-23,116,000$55.05M$55.05M$-28,169,000$-28,169,000$62.77M$62.77M$-86,499,500$-86,499,500
    Operating Expenses$23.24M$23.24M$-5,293,000$-5,293,000$56.81M$56.81M$-20,077,000$-20,077,000$76.53M$76.53M$-39,860,000$-39,860,000
    R&D$39.39M$39.39M$41.38M$41.38M$35.99M$35.99M$59.05M$59.05M$47.63M$47.63M$79.21M$79.21M
    SG&A$15.90M$15.90M$19.49M$19.49M$13.88M$13.88M$16.92M$16.92M$15.23M$15.23M$5.76M$18.97M
    Operating Income$434,500$434,500$-17,823,000$-17,823,000$-1,757,000$-1,757,000$-8,092,000$-8,092,000$-13,760,500$-13,760,500$-46,639,500$-46,639,500
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$8.73M$8.73M$1.31M$1.31M$259.36M$259.36M$8.16M$8.16M$14.53M$14.53M$-33,297,500$-33,297,500
    Income Tax Expense$604,500$604,500$224,000$224,000$31.58M$31.58M$2.15M$2.15M$1.44M$1.44M$889,500$889,500
    Net Income$7.96M$7.96M$977,500$977,500$227.48M$227.48M$5.96M$5.96M$12.90M$12.90M$-33,885,500$-33,885,500
    EBITDA$3.97M$3.97M$-14,228,000$-14,228,000$1.30M$1.30M$-5,047,500$-5,047,500$-10,634,500$-10,634,500$-44,442,000$-44,442,000
    EBIT$434,500$434,500$-17,823,000$-17,823,000$-1,757,000$-1,757,000$-8,092,000$-8,092,000$-13,760,500$-13,760,500$-46,639,500$-46,639,500
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HCM

    News

    HUTCHMED (China) Limited (HCM) Stock Price, News, Quote & History

    This Yahoo Finance page provides a comprehensive overview of HUTCHMED (China) Limited (HCM), including its current stock price of $13.50, historical performance, and key financial data. The company...

    Yahoo! Finance Canada•10/13/26•Neutral

    Hutchison China MediTech Limited (HCM) stock price, news, quote and history

    HUTCHMED (China) Limited (formerly Hutchison China MediTech Limited) is a biopharmaceutical company focused on discovering, developing...

    Yahoo Finance UK•10/13/26•Neutral

    How Investors May Respond To HUTCHMED (China) (AIM:HCM) US NDA For ORPATHYS–TAGRISSO Lung Cancer Combo

    HUTCHMED, in collaboration with AstraZeneca, has submitted a US New Drug Application for ORPATHYS plus TAGRISSO to treat EGFR-mutated NSCLC patients with MET overexpression...

    Yahoo Finance•10/13/26•Somewhat-Bullish

    What Do Hutchmed's (LSE:HCM) Latest Interim Results Reveal About Its Cancer-Drug Engine?

    Hutchmed's recent interim results reportedly fell short of some third-party estimates, which the company attributes to the lumpy nature of its income from cancer-drug partnerships. Despite this...

    Kalkine Media•10/13/26•Somewhat-Bearish

    HUTCHMED (China) (AIM:HCM) FDA Filing Puts Its Undervalued Narrative Back In Focus

    HUTCHMED (China) is experiencing renewed focus due to AstraZeneca’s FDA filing for the ORPATHYS plus TAGRISSO lung cancer combination, supported by positive Phase III data. Despite recent share price gains...

    Simply Wall Street•10/12/26•Neutral

    HCM Valuation and Fair Value

    Forward P/E
    18.1x
    P/FCF
    236.5x
    PEG
    0.0x
    P/B
    1.9x
    See GNG's fair value

    HCM Profitability: Margins, ROIC and FCF

    Gross margin
    0.2%
    Operating margin
    0.3%
    Net margin
    3.3%
    ROIC
    -2.4%
    ROE
    1.5%
    FCF margin
    1.8%
    FCF yield
    0.4%

    HCM Competitors

    CompanyTicker
    MBX Biosciences, Inc. Common StockMBX
    89bio IncETNB
    Maravai Lifesciences Holdings IncMRVI
    Supernus Pharmaceuticals IncSUPN
    Beam Therapeutics IncBEAM
    Prestige Brand Holdings IncPBH
    Sellas Life Sciences Group IncSLS
    UFP Technologies IncUFPT

    Sector: Healthcare

    HCM Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    9
    Hold
    2
    Sell
    0
    Strong Sell
    0

    HCM Bull Case vs Bear Case

    Bull case

    • 84.6% of HCM's analyst ratings are Buy or Strong Buy.

    Bear case

    • HCM beat EPS estimates in 25.0% of its last 8 reported quarters.

    HCM Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -19.9%

    Frequently Asked Questions About HCM

    Does HCM pay dividends?

    HUTCHMED DRC (HCM) does not currently pay a regular dividend.

    What is HCM's market cap?

    HUTCHMED DRC (HCM) has a market capitalization of $2.35B with a current stock price of $13.48.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In